WST vs. EXPD
Compare and contrast key facts about West Pharmaceutical Services, Inc. (WST) and Expeditors International of Washington, Inc. (EXPD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WST or EXPD.
Correlation
The correlation between WST and EXPD is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
WST vs. EXPD - Performance Comparison
Loading data...
Key characteristics
WST:
-0.71
EXPD:
0.07
WST:
-0.67
EXPD:
0.28
WST:
0.87
EXPD:
1.04
WST:
-0.65
EXPD:
0.09
WST:
-1.75
EXPD:
0.20
WST:
22.17%
EXPD:
9.76%
WST:
54.91%
EXPD:
25.80%
WST:
-59.29%
EXPD:
-58.07%
WST:
-53.63%
EXPD:
-9.55%
Fundamentals
WST:
$15.14B
EXPD:
$15.75B
WST:
$6.37
EXPD:
$6.02
WST:
33.07
EXPD:
19.10
WST:
3.54
EXPD:
4.13
WST:
5.23
EXPD:
1.42
WST:
5.64
EXPD:
6.85
WST:
$2.90B
EXPD:
$11.06B
WST:
$1.00B
EXPD:
$1.42B
WST:
$729.50M
EXPD:
$1.15B
Returns By Period
In the year-to-date period, WST achieves a -33.76% return, which is significantly lower than EXPD's 6.82% return. Over the past 10 years, WST has outperformed EXPD with an annualized return of 15.27%, while EXPD has yielded a comparatively lower 11.02% annualized return.
WST
-33.76%
3.69%
-31.00%
-38.64%
0.47%
15.27%
EXPD
6.82%
12.18%
-0.93%
1.81%
11.92%
11.02%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WST vs. EXPD — Risk-Adjusted Performance Rank
WST
EXPD
WST vs. EXPD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Expeditors International of Washington, Inc. (EXPD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WST vs. EXPD - Dividend Comparison
WST's dividend yield for the trailing twelve months is around 0.38%, less than EXPD's 1.23% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.38% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
EXPD Expeditors International of Washington, Inc. | 1.23% | 1.32% | 1.08% | 1.29% | 0.86% | 1.09% | 1.28% | 1.32% | 1.30% | 1.51% | 1.60% | 1.43% |
Drawdowns
WST vs. EXPD - Drawdown Comparison
The maximum WST drawdown since its inception was -59.29%, roughly equal to the maximum EXPD drawdown of -58.07%. Use the drawdown chart below to compare losses from any high point for WST and EXPD. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WST vs. EXPD - Volatility Comparison
West Pharmaceutical Services, Inc. (WST) and Expeditors International of Washington, Inc. (EXPD) have volatilities of 11.24% and 10.91%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WST vs. EXPD - Financials Comparison
This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Expeditors International of Washington, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WST vs. EXPD - Profitability Comparison
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
EXPD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Expeditors International of Washington, Inc. reported a gross profit of 352.86M and revenue of 2.67B. Therefore, the gross margin over that period was 13.2%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
EXPD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Expeditors International of Washington, Inc. reported an operating income of 265.86M and revenue of 2.67B, resulting in an operating margin of 10.0%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.
EXPD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Expeditors International of Washington, Inc. reported a net income of 203.80M and revenue of 2.67B, resulting in a net margin of 7.6%.